← Back to Search

Reminder System for Osteoporosis Care

N/A
Waitlist Available
Led By William D Leslie, MD MSc
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Women and men age 50 and older with a humerus fracture (physician ICD-9-CM code 812)
Women and men age 50 and older with a hip fracture (physician ICD-9-CM 820-821 plus a procedure code for site-specific fracture reduction or fixation, open or closed)
Must not have
Hip or wrist fractures without a procedure tariff
A fracture event in the previous 12 months meeting the study case definition (i.e., only a single notification per year is planned)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a notification system to remind physicians and patients of the importance of osteoporosis care after a fracture.

Who is the study for?
This trial is for men and women aged 50 or older in Manitoba who have recently had specific fractures (humerus, spine, hip with procedure, Colles' with procedure or cast) indicating possible osteoporosis. Excluded are non-residents, those under age 50, recent fracture patients, current osteoporosis medication users, and those with recent BMD tests.
What is being tested?
The study aims to improve post-fracture care by testing a notification system that alerts physicians and/or patients about fractures that suggest underlying osteoporosis. The goal is to enhance bone mineral density testing and treatment after such fractures.
What are the potential side effects?
Since the intervention involves information letters rather than medications or medical procedures, there are no direct physical side effects expected from participating in this clinical trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 50 or older and have a broken upper arm.
Select...
I am 50 or older and have had a hip fracture treated.
Select...
I am 50 or older and have had a spine fracture.
Select...
I am 50 or older and have had a specific type of wrist fracture treated.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had a hip or wrist fracture that did not require surgery.
Select...
I have had a bone fracture in the last year that fits the study's criteria.
Select...
I am currently taking medication for osteoporosis.
Select...
I am under 50 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: 2 (physician/patient)Experimental Treatment1 Intervention
Physician(s) and patient connected with a fracture that meets study inclusion criteria.
Group II: 1 (physician-only)Experimental Treatment1 Intervention
Physician(s) connected with a fracture that meets study inclusion criteria.
Group III: ControlActive Control1 Intervention
Usual care.

Find a Location

Who is running the clinical trial?

The Manitoba Bone Density Program CommitteeUNKNOWN
University of ManitobaLead Sponsor
619 Previous Clinical Trials
202,457 Total Patients Enrolled
1 Trials studying Osteoporosis
200 Patients Enrolled for Osteoporosis
The Manitoba Patient Access Network Steering CommitteeUNKNOWN

Media Library

Information letters 2023 Treatment Timeline for Medical Study. Trial Name: NCT00594789 — N/A
~245 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top